ADARx Pharmaceuticals Inc. · 2 weeks ago
Sr. Biostatistician
ADARx Pharmaceuticals Inc. is a late-clinical stage biotechnology company focused on RNA-based therapeutics. They are seeking a Senior Biostatistician to provide strategic and hands-on statistical leadership in the development of RNA-based programs, collaborating with cross-functional teams to ensure scientific rigor and regulatory compliance.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Lead statistical strategy, study design, and data analysis for RNA-based programs across discovery, preclinical, and/or clinical development
Develop statistical analysis plans (SAPs), protocols, and supporting documentation in alignment with regulatory expectations
Provide statistical expertise for dose-finding, PK/PD modeling, biomarker analysis, and translational studies
Collaborate cross-functionally with Clinical Development, Biometrics, Bioinformatics, Regulatory, and Discovery teams
Oversee and review statistical outputs from CROs and external partners, ensuring quality and adherence to timelines
Perform and interpret advanced statistical analyses using appropriate methodologies for high-dimensional and longitudinal data
Contribute to regulatory submissions, investigator brochures, clinical study reports, and scientific publications
Communicate statistical results clearly to both technical and non-technical stakeholders
Mentor junior statisticians and contribute to best practices within the biostatistics function
Qualification
Required
PhD or MS in Biostatistics, Statistics, Mathematics, or a related quantitative field
5+ years of biostatistics experience in the pharmaceutical or biotechnology industry
Direct experience supporting RNA-based therapeutics (e.g., siRNA, mRNA, antisense oligonucleotides)
Strong understanding of drug development processes, including preclinical and clinical trial design
Proficiency in statistical programming and analysis tools (e.g., SAS, R)
Experience working with CROs and managing outsourced statistical activities
Knowledge of regulatory guidelines (ICH, FDA, EMA) and submission requirements
Excellent written/verbal communication, collaboration, and problem-solving skills are essential for this role
Must be able to work independently with supervision as needed
Must be collaborative, work well with other team members in a matrix team environment
Strong organizational skills with attention to detail and accuracy
Ability to maintain a high level of confidentiality and exercise discretion
Adaptable / Flexible - willing and able to adjust to multiple demands and shifting priorities as well as an ability to meet day-to-day challenges
Understand project timelines and deliverables and plans/coordinate project work accordingly with departmental, functional, and external stakeholders
Preferred
Experience with early-phase clinical trials and translational medicine
Familiarity with bioinformatics or omics-related data analysis
Prior involvement in regulatory interactions or submissions
Demonstrated leadership or mentoring experience
Benefits
Equity-based compensation
Performance-based bonuses
401(k) with Company Match
Medical, Dental, Vision
Flexible Spending Account
Life Insurance
Employee Assistance Program
Employee Discounts
Gym Membership
Paid Vacation
Paid Holidays
Paid Sick, Jury Duty, Bereavement
Company
ADARx Pharmaceuticals Inc.
ADARx Pharmaceuticals, Inc., located in San Diego, is a clinical stage biotechnology company committed to turning cutting-edge science into life-saving therapeutics.
H1B Sponsorship
ADARx Pharmaceuticals Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2023 (1)
Funding
Current Stage
Growth StageTotal Funding
$332MKey Investors
LG Technology VenturesAscenta Capital
2025-02-01Series Unknown
2023-08-09Series C· $200M
2023-01-20Series B· $46M
Recent News
2026-01-16
ADARx Pharmaceuticals
2025-12-02
ADARx Pharmaceuticals
2025-10-20
Company data provided by crunchbase